Results 21 to 30 of about 164,829 (311)

Neoplasm Transplantation Inhibition by Uninvolved Lymph Tissue [PDF]

open access: yesNature, 1966
HETEROLOGOUS transplantation of human neoplasms into the cheek pouch of the syrian hamster (Mesocricetus auratus) was first reported in 1951 (ref. 1). The uniqueness of the pouch as a site for transplantation results from the alymphatic structure and the very slow diffusion of large molecules out of the pouch area2.
B V, Caldwell, P A, Wright
openaire   +2 more sources

Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation

open access: yesCase Reports in Hematology, 2013
Therapy-related myeloid neoplasm (t-MN) is a subtype of acute myeloid leukemia with adverse cytogenetics and poor overall prognosis despite intensive induction chemotherapy and allogeneic hematopoietic cell transplantation (allo-HCT).
Richard J. Lin   +3 more
doaj   +1 more source

Fatal progression of squamous cell carcinoma 10 years after cadaveric kidney transplantation

open access: yesВестник трансплантологии и искусственных органов, 2020
Various research has shown that non-melanocytic malignant skin lesion is one of the most common post-kidney transplant neoplasms. Multiple lesions and a more aggressive clinical course are more common in kidney transplant patients than in the general ...
I. N. Dymkov   +4 more
doaj   +1 more source

Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm. [PDF]

open access: yes, 2019
The Notch signaling pathway contributes to the pathogenesis of a wide spectrum of human cancers, including hematopoietic malignancies. Its functions are highly dependent on the specific cellular context. Gain-of-function NOTCH1 mutations are prevalent in
Chang, Yuan-I   +20 more
core   +1 more source

Renal transplantation in polycythemia vera:- A rare case report from India

open access: yesIndian Journal of Transplantation, 2020
Polycythemia vera (PV) is a rare myeloproliferative neoplasm usually associated with JAK2 mutation. Manifestations include blood circulation disorder, hypertension and cerebral infarction.
Prashant Bharat Malviya, Sanjay Maitra
doaj   +1 more source

Mouse models of myeloproliferative Neoplasms: JAK of all grades. (Review) [PDF]

open access: yes, 2011
In 2005, several groups identified a single gain-of-function point mutation in the JAK2 kinase that was present in the majority of patients with myeloproliferative neoplasms (MPNs).
Li, J.   +7 more
core   +2 more sources

Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report [PDF]

open access: yesClinical and Molecular Hepatology, 2018
Hepatic hemangioma represents the most common benign primary hepatic neoplasm. Although most such tumors are small and asymptomatic, giant hepatic hemangioma is frequently symptomatic, and requires intervention.
Ju Hyun Lee   +8 more
doaj   +1 more source

RENAL ONCOCYTOMA MANAGEMENT IN ADVANCE RENAL FAILURE. A CASE BASED REVIEW

open access: yesПраці Наукового товариства імені Шевченка. Медичні науки, 2020
The presentation of a renal mass presumes a malignancy unless proven otherwise by histologic evaluation. We present a case of 40-year-old man with advance uremia necessitating renal replacement. Radiologic images showed a right renal mass and the patient
Akbar Mahmood, Ali Lawati
doaj   +1 more source

Anastomosing hemangioma masquerading as renal cell carcinoma in a transplanted kidney: a case report. [PDF]

open access: yesClin Transplant Res
Anastomosing hemangioma (AH) is an exceptionally rare benign vascular neoplasm that can closely mimic renal cell carcinoma (RCC) on radiologic and histopathologic evaluation.
Jung HS   +4 more
europepmc   +2 more sources

Hepatocellular carcinoma associated with progressive intrahepatic familial cholestasis type 2: a case report

open access: yesClinical Transplantation and Research
Progressive familial intrahepatic cholestasis type 2 (PFIC2) is an autosomal recessive disorder typically presenting in infancy with cholestasis and rapidly progressing to cirrhosis.
João Miguel Pimentel   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy